Mirus Bio receives ISO 13485:2016 certification, underscoring the quality of processes used to support GMP product portfolio. Read more

VirusGEN AAV Kit + RevIT for 10L Culture

Proven Nucleic Acid Delivery for Large-Scale Virus Production

Description

This novel enhancer is easily integrated into existing workflows, and it produces 2-4x higher titers across a range of serotypes, cellular growth media formulations, and transfection platforms. RevIT™ AAV Enhancer can further drive down upstream manufacturing costs by permitting the use of lower levels of plasmid DNA while maintaining high-quality titers. Continual improvements in both upstream and downstream AAV manufacturing processes will allow the next generation of gene therapies to reach a broader audience.

SKU: MIR 8008

Supporting Data

 

 

 

RevIT AAV titer enhancer improves titer across serotypes when used with polymer-only transfection reagents.

 

 

 

RevIT AAV titer enhancer can be used with any media or cell line to increase titer.

 

 

VirusGEN® plus RevIT AAV titer enhancer outperformed polymer-only reagents.

 

RevIT AAV titer enhancer improves titer across serotypes when used with the VirusGEN® transfection platform.

Resources

Specifications

Storage Conditions
All Configurations: Store at -20ºC, protected from exposure to light.

Product Guarantee
All Configurations: 6 months

Usage Statement
All Configurations: For Research Use Only.

Animal Origin Statement
All Configurations: This product is animal origin free.

 

Technical Product Literature

Full Protocols
RevIT™ AAV Enhancer QRP (PDF)
VirusGEN® AAV Kit with RevIT™ AAV Enhancer Protocol (PDF)

Quick Reference Protocol
VirusGEN® AAV Kit with RevIT™ AAV Enhancer QRP (PDF)

SDS
RevIT™ AAV Enhancer SDS (PDF)
VirusGEN® AAV Kit with RevIT™ AAV Enhancer SDS (PDF)

Additional Resources

Virus Titer Reference Card: Methods to Measure Lentivirus and Adeno-associated Virus in Your Sample (PDF)

For a lot-specific Certificate of Analysis (COA) or Certificate of Origin (COO) containing a TSE/BSE Statement for this product, please contact techsupport@mirusbio.com.

FAQs

See the VirusGEN AAV FAQs

Using transfection reagents and enhancers from Mirus has given our platform a competitive advantage. Increasing efficiency and lowering costs for all of our programs.

Sally Mader, PhD
ZYZ Theraputics